Skip to Content

Stay Informed

Walsworth Publishes 2020 Life Sciences Year In Review

Walsworth publishes its 2020 Year In Review Life Sciences Update. Stay up-to-date with our discussion of recent drug litigation, including Lipitor and Lexapro, device litigation, including pelvis mesh and breast implants, talc, opioids, and trends in life sciences, including CBD, COVID-19 updates and trials, and pending U.S. Supreme Court jurisdictional litigation.

Click here to read the full report.

For more information, please contact Lisa Rice, Laurie SherwoodKatie Stricklin or Amrit Dhaliwal.